Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission ― From the CLOT-COVID Study ―

Author:

Ikeda Satoshi1,Ueno Yuki1,Maemura Koji1,Yachi Sen2,Takeyama Makoto2,Nishimoto Yuji3,Tsujino Ichizo4,Nakamura Junichi4,Yamamoto Naoto5,Nakata Hiroko6,Umetsu Michihisa7,Aikawa Shizu8,Hayashi Hiroya9,Satokawa Hirono10,Okuno Yoshinori11,Iwata Eriko12,Ogihara Yoshito13,Ikeda Nobutaka14,Kondo Akane15,Iwai Takehisa16,Yamada Norikazu17,Ogawa Tomohiro18,Kobayashi Takao5,Mo Makoto19,Yamashita Yugo11,

Affiliation:

1. Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences

2. Japan Community Health Care Organization Tokyo Shinjuku Medical Center

3. Hyogo Prefectural Amagasaki General Medical Center

4. Hokkaido University Hospital

5. Hamamatsu Medical Center

6. Yokosuka General Hospital Uwamachi

7. Tohoku University Hospital

8. Tsukuba Medical Center Hospital

9. Osaka City University Graduate School of Medicine

10. Fukushima Medical University, School of Medicine

11. Kyoto University Hospital

12. Nankai Medical Center Japan Community Health Care Organization

13. Mie University Hospital

14. Toho University Ohashi Medical Center

15. Shikoku Medical Center for Children and Adults

16. Tsukuba Vascular Center

17. Kuwana City Medical Center

18. Fukushima Daiichi Hospital

19. Yokohama Minami Kyosai Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference39 articles.

1. 1. Umeh C, Tuscher L, Ranchithan S, Watanabe K, Gupta R. Predictors of COVID-19 mortality in critically ill ICU patients: A multicenter retrospective observational study. Cureus 2022; 14: e20952. doi:10.7759/cureus.20952.

2. 2. Reyes LF, Murthy S, Garcia-Gallo E, Irvine M, Merson L, Martin-Loeches I, et al. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: A prospective, multinational, multicentre, observational study. ERJ Open Res 2022; 8: 00552–2021. doi:10.1183/23120541.00552-2021.

3. 3. Gopalan N, Senthil S, Prabakar NL, Senguttuvan T, Bhaskar A, Jagannathan M, et al. Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care: An experience from South India. PLoS One 2022; 17: e0263471. doi:10.1371/journal.pone.0263471.

4. 4. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052–2059.

5. 5. Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Áinle FN, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ 2021; 375: n2400. doi:10.1136/bmj.n2400.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3